pharmaphorum

JANUARY 24, 2022

Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.

Radiology 111

Radiology Marketing Genome Genomics 111

The Pharma Data

AUGUST 5, 2021

Group sales increase by 12.9 Sales at all divisions increased by a double-digit percentage after adjusting for currency and portfolio effects, and we expect this positive sales momentum to continue in all our businesses. Group sales in the second quarter increased by 12.9 Group sales in the second quarter increased by 12.9

Sales 52

Sales Production Gene Therapy Allergies 52

Drug Discovery World

OCTOBER 2, 2023

She has over 15 years of experience in clinical trial imaging, on both the operational and sales sides. As a subject matter expert on medical imaging, she is responsible for ICON’s imaging sales and strategy globally. European Journal of Radiology 105 (2018) 246–250 [4] Jiang, et al. References [1] John C. Preface Document.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Radiology 59

The Pharma Data

OCTOBER 1, 2021

Dr. Olaf Weber, Head of Radiology Research and Development at Bayer. About Radiology at Bayer Everyone deserves clear answers about their health, starting with an early and accurate diagnosis. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 mmol/kg weight. “At billion euros. billion euros.

Radiology 52

Radiology Life Science Development Production 52

pharmaphorum

SEPTEMBER 30, 2022

He pointed out that services to administer the injections frequently, and the required radiology and clinical monitoring for patients, “will all need to be factored in on top of the simple cost of the drug.” “It is very likely more people will come to see their doctor now – and we, as doctors, need to be ready. .”

Clinical Trials 52

Clinical Trials Clinical Trials Sales Drugs 52

pharmaphorum

MARCH 31, 2021

Billed as a future blockbuster, Lutathera added $445 million in sales last year, although its growth was pegged back by the pandemic as it needs to be administered in a hospital location. billion or more in peak sales. “We believe this technology has the potential to transform many patients’ lives,” she added.

Licensing 98

Licensing Licensing Gene Therapy Sales 98

Drug Discovery World

APRIL 8, 2024

In December 2023, Pfizer announced that it had chosen to donate the rights of its royalties from the sale of Bavencio (avelumab) in the United States to the AACR, as an acknowledgment of the AACR’s dedication to sustained innovation in cancer research and treatment.

In-Vivo 52

In-Vivo In-Vitro Antibody Protein 52

Delveinsight

DECEMBER 29, 2020

billion – a deal that is split into upfront payments, and sales and regulatory milestone payments. The company boasts of its wide spectrum of portfolio ranging from solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology, and respiratory care.

Trials 52

Trials Drugs Hormones Radiology 52

The Pharma Data

MARCH 23, 2023

Bayer estimates that the peak sales potential for Nubeqa will exceed €3 billion. The primary endpoint of this study is radiological progression-free survival (rPFS), measured by PSMA PET/CT assessed by independent central review. In fiscal 2022, the Group employed around 101,000 people and had sales of 50.7 billion euros.

Hormones 40

Hormones Trials Branding Development 40

XTalks

JUNE 12, 2023

Abbott Laboratories reported that the sales from its Diagnostics and Medical Device divisions in 2022 surpassed the company’s initial forecast. The remarkable performance in 2022 was driven largely by the sales of COVID-19 testing kits, including the BinaxNOW COVID-19 Ag test and its at-home self-test version. percent from $27.06

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

pharmaphorum

APRIL 7, 2021

The drug made $445 million in sales last year. Novartis already sells one radioligand therapy – Lutathera (177Lu- oxodotreotide) for neuroendocrine tumours – which it acquired for $3.9 billion along with its developer Advanced Accelerator Applications in 2017.

DNA 52

DNA Licensing Licensing Gene Therapy 52

The Pharma Data

DECEMBER 23, 2020

Department of Defense (DoD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) in coordination with the Office of the Assistant Secretary of Defense for Health Affairs (OASD(HA)) and the Defense Health Agency (DHA). It will be funded by the U.S.

DNA 40

DNA Vaccination Vaccine Immune Response 40

XTalks

AUGUST 30, 2022

Global sales of over-the-counter and prescription products related to central nervous system (CNS) disease added up to $86 billion in 2019. The Neurology and Radiology departments are vital for consultation and imaging, which is needed to establish baselines for a study.

Trials 83

Trials Drug Delivery Drugs Gene 83

XTalks

SEPTEMBER 14, 2020

If retail sales were the sole indicator that the US economy is recovering, the country would have something to cheer about. According to the Commerce Department, retail sales rose 7.5 Retail sales in the UK have bounced back to relatively high levels, even though initially, sales were extremely anemic, with only a 0.9

Vaccination 92

Vaccination Vaccine Antibody Life Science 92

pharmaphorum

MARCH 16, 2022

Although not strictly part of the novel-format discussion, the European Society of Radiology (ESR) has announced that its annual ECR 2022 congress will follow a ‘two-in-one‘ format: an online introductory event featuring the highlights of the scientific and educational programme of the main onsite-and-online event scheduled at a later date.

Doctors 97

Doctors Doctor Marketing Radiology 97

The Pharma Data

JUNE 25, 2021

Under the terms of the licensing agreement with Vanderbilt, AstraZeneca will pay single-digit royalties on future net sales. W911QY-21-9-0001. Preliminary ‘in vitro’ findings from investigators at Oxford University and Columbia University also demonstrate that AZD7442 neutralises recent emergent SARS-CoV-2 viral variants.

Trials 52

Trials Antibody In-Vitro Medicine 52

The Pharma Data

AUGUST 22, 2021

Under the terms of the licensing agreement with Vanderbilt, AstraZeneca will pay single-digit royalties on future net sales. W911QY-21-9-0001. About AstraZeneca.

Trials 52

Trials Antibody Vaccination Vaccine 52

The Pharma Data

MAY 3, 2021

Radiology Partners, Aidoc talk AI adoption, handling bias, FDA actions ( MedtechDive ). Siemens raises outlook as COVID-19 antigen tests blast past original sales target ( MedtechDive ). Siemens raises outlook as COVID-19 antigen tests blast past original sales target ( MedtechDive ).

Gene Therapy 52

Gene Therapy Vaccination Vaccine Bioequivalency 52